Cargando…

TAK-875 Mitigates β-Cell Lipotoxicity-Induced Metaflammation Damage through Inhibiting the TLR4-NF-κB Pathway

Metabolic inflammatory damage, characterized by Toll-like receptor 4 (TLR4) signaling activation, is a major mechanism underlying lipotoxicity-induced β-cell damage. The present study is aimed at determining whether G protein-coupled receptor 4 (GPR40) agonist can improve β-cell lipotoxicity-induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xide, Yan, Yuanli, Weng, Zhiyan, Chen, Chao, Lv, Miaoru, Lin, Qingwen, Du, Qiuxia, Shen, Ximei, Yang, Liyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942802/ https://www.ncbi.nlm.nih.gov/pubmed/31934590 http://dx.doi.org/10.1155/2019/5487962

Ejemplares similares

Metformin Reduces Lipotoxicity-Induced Meta-Inflammation in β-Cells through the Activation of GPR40-PLC-IP3 Pathway
por: Shen, Ximei, et al.
Publicado: (2019)

Macrophage SCAP Contributes to Metaflammation and Lean NAFLD by Activating STING–NF-κB Signaling Pathway
por: Huang, Xinyu, et al.
Publicado: (2022)

A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
por: Yabuki, Chiori, et al.
Publicado: (2013)

A high molar activity (18)F-labeled TAK-875 derivative for PET imaging of pancreatic β-cells
por: Dornan, Mark H., et al.
Publicado: (2018)

TAK-242 ameliorates epileptic symptoms in mice by inhibiting the TLR4/NF-κB signaling pathway
por: Dong, Jibo, et al.
Publicado: (2022)

Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus
por: Naik, H, et al.
Publicado: (2013)

Fasiglifam (TAK-875) Alters Bile Acid Homeostasis in Rats and Dogs: A Potential Cause of Drug Induced Liver Injury
por: Wolenski, Francis S., et al.
Publicado: (2017)

Weight cycling based on altered immune microenvironment as a result of metaflammation
por: Li, Wanyang, et al.
Publicado: (2023)

Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
por: Kuryłowicz, Alina, et al.
Publicado: (2020)

Complement in metabolic disease: metaflammation and a two-edged sword
por: King, B. C., et al.
Publicado: (2021)

Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury
por: Longo, Diane M, et al.
Publicado: (2019)

POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway
por: Weng, Ting, et al.
Publicado: (2017)

Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets
por: Pejnovic, Nada N, et al.
Publicado: (2013)

Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice
por: Fu, Wei, et al.
Publicado: (2020)

Alliin, An Allium sativum Nutraceutical, Reduces Metaflammation Markers in DIO Mice
por: Sánchez-Sánchez, Marina A., et al.
Publicado: (2020)

FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB
por: Kim, Mi-Jeong, et al.
Publicado: (2023)

Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways
por: Zhou, Feng, et al.
Publicado: (2018)

Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes
por: Kaku, Kohei, et al.
Publicado: (2013)

FAK mediates LPS-induced inflammatory lung injury through interacting TAK1 and activating TAK1-NFκB pathway
por: Chen, Xi, et al.
Publicado: (2022)

Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis
por: Tolusso, Barbara, et al.
Publicado: (2018)

TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
por: Yang, Wanlei, et al.
Publicado: (2021)

Fasiglifam (TAK‐875) has dual potentiating mechanisms via Gαq‐GPR40/FFAR1 signaling branches on glucose‐dependent insulin secretion
por: Sakuma, Kensuke, et al.
Publicado: (2016)

Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH
por: Tewari, Archana, et al.
Publicado: (2023)

Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice
por: Collotta, Debora, et al.
Publicado: (2020)

A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease
por: Kanbay, Mehmet, et al.
Publicado: (2019)

The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review
por: Pivonello, Claudia, et al.
Publicado: (2021)

TLR2 inhibition ameliorates the amplification effect of LPS on lipid accumulation and lipotoxicity in hepatic cells
por: Zhang, Liting, et al.
Publicado: (2021)

Natural cyclopeptide RA-V inhibits the NF-κB signaling pathway by targeting TAK1
por: Wang, Zhe, et al.
Publicado: (2018)

The TLR4‐IRE1α pathway activation contributes to palmitate‐elicited lipotoxicity in hepatocytes
por: Shen, Chen, et al.
Publicado: (2018)

HIV-1 Vpr stimulates NF-κB and AP-1 signaling by activating TAK1
por: Liu, Ruikang, et al.
Publicado: (2014)

Correction to Lancet Psychiatry 2020; 7: 875–82
Publicado: (2020)

TACI-Deficient Macrophages Protect Mice Against Metaflammation and Obesity-Induced Dysregulation of Glucose Homeostasis
por: Liu, Lunhua, et al.
Publicado: (2018)

Developmental Origins of Metaflammation; A Bridge to the Future Between the DOHaD Theory and Evolutionary Biology
por: Itoh, Hiroaki, et al.
Publicado: (2022)

Mitochondrial Methionyl-tRNA Formyltransferase Deficiency Alleviates Metaflammation by Modulating Mitochondrial Activity in Mice
por: Sun, Xiaoxiao, et al.
Publicado: (2023)

sNASP Mutation Aggravates to the TLR4-Mediated Inflammation in SLE by TAK1 Pathway
por: Bao, Yatao, et al.
Publicado: (2023)

Fasiglifam (TAK-875), a G Protein-Coupled Receptor 40 (GPR40) Agonist, May Induce Hepatotoxicity through Reactive Oxygen Species Generation in a GPR40-Dependent Manner
por: Kim, MinJeong, et al.
Publicado: (2018)

875 Prospective Monitoring of Indwelling Urinary Catheters in Hospitalized Patients
por: Yoon, Bona, et al.
Publicado: (2014)

A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice
por: Mohammad, Shireen, et al.
Publicado: (2021)

Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1
por: Hong, Chang-Soo, et al.
Publicado: (2019)

Torilin Inhibits Inflammation by Limiting TAK1-Mediated MAP Kinase and NF-κB Activation
por: Endale, Mehari, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uk92kj1g3snbeikge05es33ijg